[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 35 of about 35
1. Tripathy P, Dewan Y: Endoscopic-assisted microscopic decompression of adenoid cystic carcinoma of paranasal sinus extending to the sella: a case report and review of literature. Neurol India; 2009 Mar-Apr;57(2):197-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic-assisted microscopic decompression of adenoid cystic carcinoma of paranasal sinus extending to the sella: a case report and review of literature.
  • We performed an endoscopic assisted microsurgical decompression of an adenoid cystic carcinoma of paranasal sinus with intracranial sellar extension with good results.
  • [MeSH-major] Carcinoma, Adenoid Cystic / surgery. Decompression, Surgical / methods. Endoscopy. Microsurgery / methods. Pituitary Neoplasms / surgery. Sella Turcica / surgery

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • MedlinePlus Health Information. consumer health - Endoscopy.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19439855.001).
  • [ISSN] 0028-3886
  • [Journal-full-title] Neurology India
  • [ISO-abbreviation] Neurol India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Number-of-references] 10
  •  go-up   go-down


2. Gras Cabrerizo JR, Orús Dotú C, Montserrat Gili JR, Fabra Llopis JM, León Vintro X, De Juan Beltrán J: [Epidemiologic analysis of 72 carcinomas of the nasal cavity and paranasal sinuses]. Acta Otorrinolaringol Esp; 2006 Oct;57(8):359-63
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Epidemiologic analysis of 72 carcinomas of the nasal cavity and paranasal sinuses].
  • [Transliterated title] Análisis epidemiológico de 72 carcinomas de fosas y senos paranasales.
  • OBJECTIVE: The aim of this study is to define the epidemiological aspects of carcinoma of the nasal cavity and paranasal sinuses.
  • MATERIAL AND METHODS: We performed a retrospective study of 72 carcinomas of the nasal cavity and paranasal sinuses.
  • The site of origin was paranasal sinuses in 46 patients (64%), 30 in ethmoid sinus, 15 in maxillary sinus and 1 in sphenoid sinus.
  • Squamous cell carcinoma was the most frequent histological type in both localizations.
  • The 5-year adjusted survival rate for all patients was 60% (IC: 54-66), 36% (IC: 28-44) for paranasal sinus carcinoma and 86% (IC: 79-93) for nasal cavity carcinoma.
  • The 5-year adjusted survival rate according to the T distribution in 46 carcinomas paranasal sinus was 80% T2, 71% T3, 19% T4a and 6% T4b.(p = 0.0002).
  • CONCLUSIONS: Carcinoma of nasal cavity and paranasal sinuses represent a group of tumors that differ from the rest of carcinomas of the head and neck.
  • [MeSH-major] Nasal Cavity. Nose Neoplasms / epidemiology. Paranasal Sinus Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17117693.001).
  • [ISSN] 0001-6519
  • [Journal-full-title] Acta otorrinolaringológica española
  • [ISO-abbreviation] Acta Otorrinolaringol Esp
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


3. Kashiwagi N, Nakanishi K, Kozuka T, Sato Y, Tanaka K, Tsukaguchi I, Uemura H, Fujii T, Yoshino K, Tomiyama N: Vascular supply with angio-CT for superselective intra-arterial chemotherapy in advanced maxillary sinus cancer. Br J Radiol; 2010 Feb;83(986):171-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vascular supply with angio-CT for superselective intra-arterial chemotherapy in advanced maxillary sinus cancer.
  • We applied this system for advanced maxillary cancer to expose its feeding arteries and their supplying territories.
  • In addition to the maxillary artery, extramaxillary feeding arteries were usually observed, including the ophthalmic, accessory meningeal, facial, transverse facial and ascending palatine arteries.
  • [MeSH-major] Contrast Media / administration & dosage. Infusions, Intra-Arterial / methods. Maxillary Sinus Neoplasms / blood supply

  • Genetic Alliance. consumer health - Sinus cancer.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for maxillary sinus cancer .
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for sinus cancer .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 2000 Mar;174(3):845-51 [10701637.001]
  • [Cites] Cancer. 2002 Mar 1;94(5):1476-82 [11920504.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1973 Jul;118(3):517-27 [4723177.001]
  • [Cites] J Comput Assist Tomogr. 2008 May-Jun;32(3):397-402 [18520544.001]
  • [Cites] AJNR Am J Neuroradiol. 1983 Mar-Apr;4(2):149-53 [6405593.001]
  • [Cites] Acta Otolaryngol Suppl. 2007 Dec;(559):151-6 [18340587.001]
  • [Cites] Radiology. 1976 Oct;121(1):99-104 [959564.001]
  • (PMID = 20139264.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Contrast Media
  • [Number-of-references] 7
  • [Other-IDs] NLM/ PMC3473533
  •  go-up   go-down


Advertisement
4. Cui D, Xie F, Zhang X: [Expression and clinical significance of cyclooxygenase-2 in nasal and paranasal sinus carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Jul;22(14):629-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression and clinical significance of cyclooxygenase-2 in nasal and paranasal sinus carcinoma].
  • OBJECTIVE: To investigate the relationship between the expression of cyclooxygenase-2 (COX-2) and the carcinogenesis and invasive behavior of nasal and paranasal sinus carcinoma (NPSC).
  • [MeSH-major] Cyclooxygenase 2 / metabolism. Nose Neoplasms / metabolism. Paranasal Sinus Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18841789.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] EC 1.14.99.1 / Cyclooxygenase 2; EC 1.14.99.1 / PTGS2 protein, human
  •  go-up   go-down


5. Zhang T, Jia H, Wang J, Shan Y, Luo S, Tang Z: [Clinical significance of the expression of p53, p63 and p73 in nasal and paranasal sinus carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct;22(20):919-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinical significance of the expression of p53, p63 and p73 in nasal and paranasal sinus carcinoma].
  • OBJECTIVE: To study the clinical significance of the expression of p53, p63 and p73 protein and the correlation of p53 and p63 in nasal and paranasal sinus carcinoma (NPSC).
  • METHOD: The immunohistochemical technique was used to detect the expression of p53, p63 and p73 in 67 cases of NPSC, para-cancer tissues and non-cancer tissues.
  • RESULT: The positive rate of p53 and p63 protein in NPSC was significantly higher than that in park cancer tissues and non-cancer tissues (P<0.01), and there were a positive correlation between the expression of p53 and p63 protein in NPSC (P<0.01).
  • But the expression of p73 had no significant difference among NPSC, para-cancer tissues and non-cancer tissues (P>0.05).
  • [MeSH-major] Carcinoma, Squamous Cell / metabolism. DNA-Binding Proteins / metabolism. Nose Neoplasms / metabolism. Nuclear Proteins / metabolism. Paranasal Sinus Neoplasms / metabolism. Trans-Activators / metabolism. Tumor Suppressor Protein p53 / metabolism. Tumor Suppressor Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19119599.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Randomized Controlled Trial
  • [Publication-country] China
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / Nuclear Proteins; 0 / TP63 protein, human; 0 / Trans-Activators; 0 / Transcription Factors; 0 / Tumor Suppressor Protein p53; 0 / Tumor Suppressor Proteins; 0 / tumor suppressor protein p73
  •  go-up   go-down


6. Hofkamp LE, Bradley S, Geliebter J, Timms BG: Atypical fetal prostate development is associated with ipsilateral hypoplasia of the wolffian ducts in the ACI rat. Anat Rec (Hoboken); 2010 May;293(5):747-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Because the ACI rat is also used as a model for prostate research, it is important to examine the relationship of IHP and urogenital sinus (UGS) development.
  • Alterations to normal prenatal development of the male accessory sex organs can have important consequences for the growth and morphology of the adult gland.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Oncol. 2007 Jul;31(1):113-20 [17549411.001]
  • [Cites] Anat Rec. 1953 Apr;115(4):635-9 [13040799.001]
  • [Cites] Prostate. 2008 May 1;68(6):629-39 [18213636.001]
  • [Cites] Environ Health Perspect. 2008 Jul;116(7):867-72 [18629307.001]
  • [Cites] Differentiation. 2008 Jul;76(6):565-77 [18462432.001]
  • [Cites] Horm Res. 2007;67(3):142-51 [17077643.001]
  • [Cites] Endocrinology. 2001 Dec;142(12):5124-30 [11713205.001]
  • [Cites] Prostate. 2005 May 1;63(2):169-86 [15486989.001]
  • [Cites] Cancer Res. 2005 Apr 1;65(7):2610-6 [15805257.001]
  • [Cites] Proc Soc Exp Biol Med. 1956 Feb;91(2):312-4 [13297786.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 10;102(19):7014-9 [15867144.001]
  • [Cites] Mamm Genome. 2006 Jul;17(7):751-9 [16845468.001]
  • [Cites] Cancer Res. 2006 Aug 1;66(15):7793-800 [16885383.001]
  • [Cites] Ann N Y Acad Sci. 2001 Dec;948:9-12 [11795399.001]
  • [Cites] Cancer Sci. 2003 Nov;94(11):974-9 [14611674.001]
  • [Cites] J Urol. 2004 Oct;172(4 Pt 2):1753-6; discussion 1756 [15371806.001]
  • [Cites] Teratology. 1970 Aug;3(3):245-9 [5471178.001]
  • [Cites] Teratology. 1975 Aug;12(1):27-32 [1162622.001]
  • [Cites] J Natl Cancer Inst. 1975 Dec;55(6):1437-45 [1206762.001]
  • [Cites] Lab Anim. 1977 Oct;11(4):247-9 [926754.001]
  • [Cites] Urology. 1978 Jan;11(1):58-61 [622762.001]
  • [Cites] Invest Urol. 1979 Jul;17(1):78-82 [447490.001]
  • [Cites] Lab Anim. 1979 Oct;13(4):325-7 [529770.001]
  • [Cites] Lab Invest. 1980 Dec;43(6):517-22 [7442127.001]
  • [Cites] J Urol. 1982 Jan;127(1):155-8 [7057491.001]
  • [Cites] J Urol. 1982 Nov;128(5):1040-3 [7176032.001]
  • [Cites] Urol Res. 1984;12(3):165-70 [6485184.001]
  • [Cites] Toxicol Pathol. 1986;14(2):168-74 [3764314.001]
  • [Cites] Exp Mol Pathol. 1990 Apr;52(2):202-11 [2332037.001]
  • [Cites] Biol Reprod. 1991 Aug;45(2):308-21 [1786296.001]
  • [Cites] J Urol. 1994 May;151(5):1427-32 [8158800.001]
  • [Cites] Cancer. 1994 Aug 1;74(3 Suppl):1030-44 [8039137.001]
  • [Cites] Cancer Res. 1994 Dec 1;54(23):6129-32 [7525054.001]
  • [Cites] Hereditas. 1995;123(2):97-101 [8984098.001]
  • [Cites] Carcinogenesis. 1997 Aug;18(8):1595-601 [9276635.001]
  • [Cites] J Urol. 1999 May;161(5):1694-701 [10210442.001]
  • [Cites] Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):134-8 [18226066.001]
  • (PMID = 20091891.001).
  • [ISSN] 1932-8494
  • [Journal-full-title] Anatomical record (Hoboken, N.J. : 2007)
  • [ISO-abbreviation] Anat Rec (Hoboken)
  • [Language] ENG
  • [Grant] United States / NIEHS NIH HHS / ES / ES013806-01; United States / NIEHS NIH HHS / ES / R21 ES013806; United States / NIEHS NIH HHS / ES / R21 ES013806-01; United States / NIEHS NIH HHS / ES / R21-ES013806
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Androgens
  • [Other-IDs] NLM/ NIHMS286997; NLM/ PMC3106341
  •  go-up   go-down


7. Gras Cabrerizo JR, Sarandeses García A, Montserrat I Gili JR, Orús Dotú C: [Revision of carcinomas in paranasal sinuses]. Acta Otorrinolaringol Esp; 2007 Jun-Jul;58(6):266-75
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Revision of carcinomas in paranasal sinuses].
  • [Transliterated title] Revisión de los carcinomas de senos paranasales.
  • The annual incidence rate for paranasal sinus cancer is quite low in Europe at approximately 1 case a year per 100 000 inhabitants.
  • The most frequent site is the maxillary sinus; in some countries such as Spain, however, carcinomas of the ethmoidal sinus complex are more prevalent.
  • Squamous cell carcinoma is the most frequent histological type and adenocarcinoma is the one with the best prognosis.
  • Lymph node involvement at diagnosis or in the course of the disease is infrequent, so prophylactic lymph node treatment would therefore not be indicated.
  • [MeSH-major] Paranasal Sinus Neoplasms

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17663948.001).
  • [ISSN] 0001-6519
  • [Journal-full-title] Acta otorrinolaringológica española
  • [ISO-abbreviation] Acta Otorrinolaringol Esp
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 105
  •  go-up   go-down


8. Chan LP, Wang LF, Tai CF, Wu CC, Kuo WR: Huge sphenoid sinus olfactory neuroblastoma: a case report. Kaohsiung J Med Sci; 2009 Feb;25(2):87-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Huge sphenoid sinus olfactory neuroblastoma: a case report.
  • Intranasal or paranasal sinus olfactory neuroblastoma is a rare malignant neoplasm of olfactory neuroepithelial origin, accounting for approximately 5% of paranasal sinus cancers.
  • However, the origin and isolation of olfactory neuroblastomas to the sphenoid sinus is exceedingly rare.
  • Only four cases of olfactory neuroblastoma isolated in the sphenoid sinus have been described in English literature and the frequency of presenting symptoms with cranial neuropathies and headache.
  • We report a case of primary sphenoid sinus olfactory neuroblastoma with the greatest enlargement reported to date.
  • [MeSH-major] Esthesioneuroblastoma, Olfactory / pathology. Nasal Cavity. Paranasal Sinus Neoplasms / pathology. Sphenoid Sinus

  • Genetic Alliance. consumer health - Neuroblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19321412.001).
  • [ISSN] 1607-551X
  • [Journal-full-title] The Kaohsiung journal of medical sciences
  • [ISO-abbreviation] Kaohsiung J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China (Republic : 1949- )
  • [Number-of-references] 11
  •  go-up   go-down


9. Zhang YP, Huang DL: [Expression of survivin in nasal and paranasal sinus carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Nov;41(11):843-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression of survivin in nasal and paranasal sinus carcinoma].
  • OBJECTIVE: To assess the protein expression of a new inhibitor of apoptosis, survivin, and its correlation with spontaneous apoptosis, tumor clinicopathological parameters and prognosis in nasal and paranasal sinus carcinoma (NPSC).
  • [MeSH-major] Apoptosis. Inhibitor of Apoptosis Proteins / metabolism. Paranasal Sinus Neoplasms / metabolism. Paranasal Sinus Neoplasms / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17283539.001).
  • [ISSN] 1673-0860
  • [Journal-full-title] Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  • [ISO-abbreviation] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Inhibitor of Apoptosis Proteins
  •  go-up   go-down


10. Hicsonmez A, Andrieu MN, Karaca M, Kurtman C: Treatment outcome of nasal and paranasal sinus carcinoma. J Otolaryngol; 2005 Dec;34(6):379-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment outcome of nasal and paranasal sinus carcinoma.
  • PURPOSE: Most authors recommend aggressive management for sinonasal carcinoma treatment.
  • In an attempt to determine the optimal treatment, we assessed the treatment results of our patients with nasal cavity and paranasal sinus carcinoma.
  • MATERIALS AND METHODS: From January 1980 to December 2001, 40 patients with malignant tumours of the nasal cavity and the paranasal sinuses were treated.
  • Thirty-two patients had tumours originating from the maxillary sinus.
  • [MeSH-major] Carcinoma, Squamous Cell / therapy. Nasal Cavity. Nose Neoplasms / therapy. Paranasal Sinus Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Male. Maxillary Sinus Neoplasms / mortality. Maxillary Sinus Neoplasms / therapy. Middle Aged. Multivariate Analysis. Neoplasm Recurrence, Local. Neoplasm Staging. Prognosis. Radiotherapy, Adjuvant. Retrospective Studies. Survival Rate. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16343397.001).
  • [ISSN] 0381-6605
  • [Journal-full-title] The Journal of otolaryngology
  • [ISO-abbreviation] J Otolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  •  go-up   go-down


11. Wang X, Zhang X, Dong L, Liu H, Gillin M, Ahamad A, Ang K, Mohan R: Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys; 2005 Oct 1;63(2):594-601
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Effectiveness of noncoplanar IMRT planning using a parallelized multiresolution beam angle optimization method for paranasal sinus carcinoma.
  • METHODS AND MATERIALS: The PMBAO approach uses a combination of coplanar and noncoplanar beam configurations for intensity-modulated radiation therapy (IMRT) treatment planning of paranasal sinus cancers.
  • To test this approach, treatment for 10 patients with paranasal sinus cancer was planned using a total of 5 beams from a pool of 46 possible beam angles.
  • RESULTS: The noncoplanar beam configuration was superior in most paranasal sinus carcinoma cases.
  • [MeSH-major] Paranasal Sinus Neoplasms / radiotherapy. Radiotherapy Planning, Computer-Assisted / methods. Radiotherapy, Conformal / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16168851.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Wang JH, Lee JH, Han JH, Lee BJ, Jang YJ: Contralateral maxillary sinus lesions in patients with nasal cavity and/or paranasal sinus carcinoma: analysis of computed tomography findings. Ann Otol Rhinol Laryngol; 2008 Dec;117(12):909-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contralateral maxillary sinus lesions in patients with nasal cavity and/or paranasal sinus carcinoma: analysis of computed tomography findings.
  • OBJECTIVES: The incidence of bilateral maxillary sinus carcinoma is very low in patients with primary maxillary sinus carcinoma.
  • However, surgeons should perform careful diagnosis of any contralateral maxillary sinus lesions to avoid missing a second primary maxillary sinus carcinoma.
  • We therefore investigated the computed tomography (CT) findings of the contralateral maxillary sinus in patients with nasal cavity and/or paranasal sinus carcinoma.
  • METHODS: Between August 1994 and September 2006, 66 patients (41 male, 25 female; age range, 22 to 85 years; mean age, 56.9 years) with nasal and/or paranasal sinus carcinoma were treated.
  • Both masses were diagnosed histologically as poorly differentiated squamous cell carcinoma.
  • During the follow-up period, no definite abnormality suggesting tumor development in the contralateral maxillary sinus was detected.
  • CONCLUSIONS: Even though most contralateral maxillary sinus lesions are benign and the incidence of bilateral maxillary sinus carcinoma is very low, second primary maxillary sinus carcinoma should be kept in mind in the differential diagnosis of contralateral maxillary sinus lesions in patients with nasal cavity and/or paranasal sinus carcinoma.
  • [MeSH-major] Carcinoma / pathology. Maxillary Sinus / pathology. Nose Neoplasms / pathology. Paranasal Sinus Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19140537.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


13. Dulguerov P, Allal AS: Nasal and paranasal sinus carcinoma: how can we continue to make progress? Curr Opin Otolaryngol Head Neck Surg; 2006 Apr;14(2):67-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nasal and paranasal sinus carcinoma: how can we continue to make progress?
  • PURPOSE OF REVIEW: New developments in the nasal and paranasal sinus cancers are reviewed.
  • RECENT FINDINGS: In addition to woodworking, several risk factors for nasal and paranasal sinus cancers have been identified, most notably smoking.
  • Progress in the differential diagnosis of small round cell nasal and paranasal sinus cancers allows the precise diagnosis of esthesioneuroblastoma.
  • Major developments include endoscopic resection of nasal and paranasal sinus cancers, high-precision radiotherapy techniques such as intensity-modulated radiotherapy, and proton-beam radiotherapy.
  • Although chemotherapy is important for aggressive neoplasms, its generalized use for nasal and paranasal sinus cancers awaits the application/development of newer drugs.
  • SUMMARY: Progress in the treatment of nasal and paranasal sinus cancers could be achieved through better prevention and the developments of more selective treatments such as endoscopic resection, high-precision radiotherapy, and new chemotherapy drugs.
  • [MeSH-major] Carcinoma. Nasal Cavity / pathology. Nose Neoplasms. Paranasal Sinus Neoplasms

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16552261.001).
  • [ISSN] 1068-9508
  • [Journal-full-title] Current opinion in otolaryngology & head and neck surgery
  • [ISO-abbreviation] Curr Opin Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 61
  •  go-up   go-down


14. Wang JH, Lee BJ, Lee JH, Kim IJ, Jang YJ: Development of mucosal thickening after radiotherapy in contralateral sinuses of patients with nasal cavity and/or paranasal sinus carcinoma. Ann Otol Rhinol Laryngol; 2008 Nov;117(11):844-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of mucosal thickening after radiotherapy in contralateral sinuses of patients with nasal cavity and/or paranasal sinus carcinoma.
  • OBJECTIVES: The aim of this study was to investigate the development of radiotherapy (RT)-induced mucosal thickening (MT) of the contralateral sinuses in patients with nasal cavity and/or paranasal sinus carcinoma.
  • CONCLUSIONS: Use of RT in patients with nasal cavity and/or paranasal sinus carcinoma may cause a significant increase in the incidence of MT and in the LM scores in all sites of the paranasal sinuses by 3 months after RT, after which the LM score decreases gradually.
  • [MeSH-major] Carcinoma / radiotherapy. Nasal Mucosa / diagnostic imaging. Nose Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / radiotherapy. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19102131.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


15. Boussen H, Khedim A, Touati S, Ben Rejeb I, Zainine R, Gritli S, Gammoudi A, Benna F, Ladgham A: [Epidemiology of nasal and paranasal sinus cancer in Tunisia]. Ann Otolaryngol Chir Cervicofac; 2006 Jun;123(3):115-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Epidemiology of nasal and paranasal sinus cancer in Tunisia].
  • [Transliterated title] Epidémiologie des cancers du massif facial en Tunisie.
  • OBJECTIVE: To report the epidemiological and clinical features of nasal and paranasal sinus cancers collected during a period of 35 years at the Salah Azaiez Institute of Tunis.
  • MATERIAL AND METHODS: This retrospective study concerned patients with histologically confirmed nasal and paranasal sinus cancers treated at our institute from 1969 to 2004.
  • Epidermoid carcinoma (47%) and adenocarcinoma (16%) predominated followed by sarcoma (14%) and melanoma (6%).
  • CONCLUSION: Nasal and paranasal cancers in Tunisia are linked more to chronic rhino-sinusal inflammation than professional exposition (wood).
  • [MeSH-major] Nose Neoplasms / epidemiology. Paranasal Sinus Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Sinus cancer.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16840900.001).
  • [ISSN] 0003-438X
  • [Journal-full-title] Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris
  • [ISO-abbreviation] Ann Otolaryngol Chir Cervicofac
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


16. Szutkowski Z, Kawecki A, Wasilewska-Teśluk E, Kraszewska E: [Results of treatment in patients with paranasal sinus carcinoma. Analysis of prognostic factors]. Otolaryngol Pol; 2008;62(1):37-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Results of treatment in patients with paranasal sinus carcinoma. Analysis of prognostic factors].
  • Analysis was based on the results of successful and unsuccessful treatment of 137 patients with paranasal sinus cancer at the Oncology Centre in Warsaw between 1987-2002.
  • [MeSH-major] Carcinoma / radiotherapy. Carcinoma / surgery. Paranasal Sinus Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18637419.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


17. Lalami Y, Vereecken P, Dequanter D, Lothaire P, Awada A: Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumors. Curr Opin Oncol; 2006 May;18(3):258-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumors.
  • PURPOSE OF REVIEW: This is a review about recent clinical developments in rare cancers of the head and neck.
  • SUMMARY: As salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck are rare malignancies, these tumors must be treated in specialized anticancer centers with access to the latest surgical and irradiation techniques.
  • [MeSH-major] Carcinoma / therapy. Head and Neck Neoplasms / therapy. Melanoma / therapy. Paranasal Sinus Neoplasms / therapy. Salivary Gland Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Salivary Gland Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16552238.001).
  • [ISSN] 1531-703X
  • [Journal-full-title] Current opinion in oncology
  • [ISO-abbreviation] Curr Opin Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drugs, Investigational
  • [Number-of-references] 85
  •  go-up   go-down


18. Sheng K, Molloy JA, Larner JM, Read PW: A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol; 2007 Feb;82(2):174-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A dosimetric comparison of non-coplanar IMRT versus Helical Tomotherapy for nasal cavity and paranasal sinus cancer.
  • PURPOSES: To determine if there are clinically significant differences between the dosimetry of sinus tumors delivered by non-coplanar LINAC-based IMRT techniques and Helical Tomotherapy (HT).
  • However, HT lacks non-coplanar capability, which is commonly used for linear accelerator-based IMRT for nasal cavity and paranasal sinus tumors.
  • METHODS AND MATERIALS: We selected 10 patients with representative early and advanced nasal cavity and paranasal sinus malignancies treated with a preoperative dose of 50 Gy/25 fractions without coverage of the cervical lymphatics for dosimetric comparison.
  • A non-coplanar seven field technique was used in all Corvus plans with five mid-sagittal fields and two anterior oblique fields as described by Claus et al. [F. Claus, W. De Gersem, C.
  • De Wagter, et al., An implementation strategy for IMRT of ethmoid sinus cancer and bilateral sparing of the optic pathways, Int J Radiat Oncol Biol Phys 51 (2001) 318-331], whereas only coplanar beamlets were used in HT planning.
  • CONCLUSIONS: Overall HT provided equivalent or slightly better normal structure avoidance with a more uniform PTV dose for nasal cavity and paranasal sinus cancer treatment than non-coplanar LINAC-based IMRT.

  • Genetic Alliance. consumer health - Sinus cancer.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17275112.001).
  • [ISSN] 0167-8140
  • [Journal-full-title] Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • [ISO-abbreviation] Radiother Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


19. Terezakis SA, Bohle GC 3rd, Lee NY: Fistula formation after postoperative radiation treatment for paranasal sinus cancer. Am J Clin Oncol; 2008 Apr;31(2):199-204
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fistula formation after postoperative radiation treatment for paranasal sinus cancer.
  • Postoperative radiation is frequently used in the treatment paradigm for paranasal sinus tumors.
  • At Memorial Sloan-Kettering Cancer Center, a radiation dose of 70 Gy is routinely prescribed to gross tumor, and 59.4 Gy is prescribed to a clinical target volume at high risk for subclinical disease and 54 Gy is delivered to a clinical target volume at low risk for subclinical disease.
  • Nonetheless, combined modality therapy is recommended for aggressive treatment of paranasal sinus tumors to inhibit local progression.
  • This report describes the clinical scenario and management of the rare incidence of fistula formation after radiation for paranasal sinus malignancy.
  • [MeSH-major] Fistula / etiology. Paranasal Sinus Diseases / etiology. Paranasal Sinus Neoplasms / radiotherapy. Radiotherapy, Conformal / adverse effects


20. Meyer JE, Brocks C, Lamcke P, Strege RJ, Maune S, Mehdorn HM, Wollenberg B, Kovacs G: [Brachytherapy in combination with function-preserving surgery of cancer of the paranasal sinus]. Laryngorhinootologie; 2010 Jun;89(6):358-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Brachytherapy in combination with function-preserving surgery of cancer of the paranasal sinus].
  • BACKGROUND: Prognosis of patients with advanced/recurrent cancer of paranasal sinuses and orbit with infiltration of the skull base is very bad.
  • We present the results of a function-preserving surgery in combination with interstitial, image adapted brachytherapy (IABT) for the treatment of these cancers.
  • METHODS AND PATIENTS: Ten patients with paranasal sinus cancer and 16 patients with sarcomas (n=26) were retrospectively analysed.
  • The three years overall survival was 60% for rhabdomyosarcoma, and 33% for the paranasal sinus cancers.
  • CONCLUSIONS: These results show that a combined treatment of function-preserving surgery and a IABT is a feasible, successful and well-tolerated option for curative, salvage and palliative therapy for selected patients with advanced or recurrent carcinoma of the paranasal sinuses and orbit.
  • [MeSH-major] Brachytherapy / methods. Carcinoma, Squamous Cell / radiotherapy. Carcinoma, Squamous Cell / surgery. Orbit / pathology. Paranasal Sinus Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / surgery. Rhabdomyosarcoma / radiotherapy. Rhabdomyosarcoma / surgery. Skull Base / pathology

  • Genetic Alliance. consumer health - Sinus cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Georg Thieme Verlag KG Stuttgart, New York.
  • (PMID = 20352601.001).
  • [ISSN] 1438-8685
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


21. Hoppe BS, Stegman LD, Zelefsky MJ, Rosenzweig KE, Wolden SL, Patel SG, Shah JP, Kraus DH, Lee NY: Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. Int J Radiat Oncol Biol Phys; 2007 Mar 1;67(3):691-702
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.
  • PURPOSE: To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center.
  • METHODS AND MATERIALS: Between January 1987 and July 2005, 85 patients with PNS and nasal cavity cancer underwent postoperative RT.
  • Most patients had squamous cell carcinoma (49%; n = 42), T4 tumors (52%; n = 36), and the maxillary sinus (53%; n = 45) as the primary disease site.
  • CONCLUSION: Complete surgical resection followed by adjuvant RT is an effective and safe approach in the treatment of PNS cancer.
  • [MeSH-major] Carcinoma, Squamous Cell / radiotherapy. Nasal Cavity. Nose Neoplasms / radiotherapy. Radiotherapy, Conformal / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Analysis of Variance. Child. Combined Modality Therapy / methods. Female. Follow-Up Studies. Humans. Male. Maxillary Sinus Neoplasms / mortality. Maxillary Sinus Neoplasms / radiotherapy. Maxillary Sinus Neoplasms / surgery. Middle Aged. Paranasal Sinus Neoplasms / mortality. Paranasal Sinus Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / surgery. Postoperative Period. Prognosis. Radiotherapy Dosage. Radiotherapy, Intensity-Modulated / adverse effects. Radiotherapy, Intensity-Modulated / methods. Salvage Therapy. Survival Rate

  • Genetic Alliance. consumer health - Sinus cancer.
  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17161557.001).
  • [ISSN] 0360-3016
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


22. Hoppe BS, Nelson CJ, Gomez DR, Stegman LD, Wu AJ, Wolden SL, Pfister DG, Zelefsky MJ, Shah JP, Kraus DH, Lee NY: Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys; 2008 Nov 1;72(3):763-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
  • PURPOSE: To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy.
  • METHODS AND MATERIALS: Between January 1990 and December 2006, 39 patients with unresectable Stage IVB paranasal sinus carcinoma were treated definitively with chemotherapy plus radiotherapy (n = 35, 90%) or with radiotherapy alone (n = 4, 10%).
  • CONCLUSIONS: Treatment outcomes for unresectable paranasal sinus carcinoma are poor, and combined-modality treatment is needed that is both more effective and associated with less morbidity.
  • [MeSH-major] Nose Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. PLATINUM COMPOUNDS .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18395361.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Platinum Compounds
  •  go-up   go-down


23. Strek P, Oleś K, Składzień J, Tomik J, Gajec S, Kocoń S, Dutsch-Wicherek M, Hartwich P, Szaleniec J: [Quality of life in patients treated for cancer of paranasal sinus and other area at head and neck]. Przegl Lek; 2010;67(12):1298-301
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Quality of life in patients treated for cancer of paranasal sinus and other area at head and neck].
  • AIM: The oncology efficiency and quality of life are both important for patients with head and neck cancer in every-day life.
  • The primary location of the tumor was: paranasal sinuses, oral cavity, oropharynx, hypopharynx and larynx.
  • The first group consist of maxillectomy patients wearing obturator protheses, the second one were treated for cancer located in other mentioned area.
  • Method of treatment and stage of head and neck cancer greatly affected dysphagia-related quality of life.
  • CONCLUSION: The MDADI is the validated and reliable self-administered questionnaire designed specifically for evaluating the impact of dysphagia on the quality of life of patients with head and neck cancer.
  • [MeSH-minor] Adult. Causality. Comorbidity. Female. Humans. Male. Middle Aged. Neoplasm Staging. Paranasal Sinus Neoplasms / epidemiology. Paranasal Sinus Neoplasms / pathology. Paranasal Sinus Neoplasms / therapy. Poland / epidemiology. Surveys and Questionnaires


24. Vieillot S, Boisselier P, Aillères N, Hay MH, Dubois JB, Azria D, Fenoglietto P: [Paranasal sinus carcinoma]. Cancer Radiother; 2010 Nov;14 Suppl 1:S52-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Paranasal sinus carcinoma].
  • [Transliterated title] Cancer des sinus de la face.
  • Cancers of the paranasal sinuses are rare tumors, with treatment based on a multidisciplinary approach.
  • Purpose of this study was to specify radioanatomy and conformal radiation modalities for cancers of the sinuses, and is illustrated by a case report.
  • [MeSH-major] Paranasal Sinus Neoplasms / radiotherapy. Paranasal Sinuses / anatomy & histology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Masson SAS. All rights reserved.
  • (PMID = 21129670.001).
  • [ISSN] 1769-6658
  • [Journal-full-title] Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
  • [ISO-abbreviation] Cancer Radiother
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


25. McKay SP, Shibuya TY, Armstrong WB, Wong HS, Panossian AM, Ager J, Mathog RH: Cell carcinoma of the paranasal sinuses and skull base. Am J Otolaryngol; 2007 Sep-Oct;28(5):294-301
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cell carcinoma of the paranasal sinuses and skull base.
  • PURPOSE: To evaluate patients with squamous cell carcinoma of the paranasal sinus and skull base for factors that might predict clinical outcome.
  • RESULTS: Of 73 patients with anterior skull base malignancies, squamous cell carcinoma was the most prevalent-30 patients or 41%.
  • Although 3- and 5-year survival of tumors free of sphenoid sinus, dura, retromaxillary, and ptyerygoid space, and orbit treated with surgery showed no significant difference to those patients with involvement, their median time of survival was increased for all anatomical regions.
  • CONCLUSIONS: Squamous cell carcinoma of the sinus invading the skull base carries a very poor prognosis regardless of treatment modality.
  • [MeSH-major] Carcinoma, Squamous Cell / therapy. Paranasal Sinus Neoplasms / therapy. Skull Base Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17826529.001).
  • [ISSN] 0196-0709
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Zhang Y, Huang D, Yu G: Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas. Acta Otolaryngol; 2005 Dec;125(12):1345-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
  • CONCLUSIONS: The inverse correlation found in this study between survivin expression and the level of spontaneous apoptosis in nasal and paranasal sinus carcinoma (NPSC) suggests that survivin may play an important role in the tumorigenesis of NPSC.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Microtubule-Associated Proteins / metabolism. Neoplasm Proteins / metabolism. Nose Neoplasms / pathology. Paranasal Sinus Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16303685.001).
  • [ISSN] 0001-6489
  • [Journal-full-title] Acta oto-laryngologica
  • [ISO-abbreviation] Acta Otolaryngol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Norway
  • [Chemical-registry-number] 0 / BIRC5 protein, human; 0 / Biomarkers, Tumor; 0 / Inhibitor of Apoptosis Proteins; 0 / Microtubule-Associated Proteins; 0 / Neoplasm Proteins
  •  go-up   go-down


27. Gołabek W, Gołabek E, Szymańska A: [Invasion of the orbit in paranasal sinus tumours]. Otolaryngol Pol; 2007;61(5):764-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Invasion of the orbit in paranasal sinus tumours].
  • The extension of paranasal sinus cancer into the orbit is one of arguments for carrying out orbital exenteration.
  • Until the advent of high-resolution computed tomography, en bloc radical resection, including the orbit, was the most effective method of treating a cancer, whose size could not be adequately judged before surgery.
  • Different clinical situations relating the orbital content to sinus tumour and their management are discussed.
  • [MeSH-major] Orbital Neoplasms / pathology. Paranasal Sinus Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18552015.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 27
  •  go-up   go-down


28. Gerlinger I, Gobel G, Tóth E, Szanyi I, Weninger C: Primary carcinoma of the frontal sinus: a case report and a review of literature. Eur Arch Otorhinolaryngol; 2008 May;265(5):593-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary carcinoma of the frontal sinus: a case report and a review of literature.
  • Paranasal sinus cancer is rather rare, with an incidence of less than 1 per 100,000 per year, the frontal sinus being the primary site in only 0.3%.
  • Following clinical and radiological examinations, the diagnosis often remains elusive, the condition mistakenly being considered to involve mucocele, pyocele or osteomyelitis.
  • This article reports on a 60-year-old pigeon breeder with squamous cell carcinoma originating in the frontal sinus.
  • [MeSH-major] Frontal Sinus. Paranasal Sinus Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17952448.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 24
  •  go-up   go-down


29. Zhang X, Wang X, Dong L, Liu H, Mohan R: A sensitivity-guided algorithm for automated determination of IMRT objective function parameters. Med Phys; 2006 Aug;33(8):2935-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A lung cancer treatment plan designed with the SGPO method was used to demonstrate that IMRT plans could be designed to favor a structure with the highest target sensitivity and spare the structures with the least target sensitivity without compromising the target coverage.
  • Using one case each of prostate and paranasal sinus cancers, we also demonstrated that several alternative optimal solutions could be designed with the SGPO algorithm favoring different structures.
  • Finally, we applied the method to eight oropharyngeal cancer cases to obtain objective function parameters that satisfied the Radiation Therapy Oncology Group RTOG-H-0022 protocol.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16964872.001).
  • [ISSN] 0094-2405
  • [Journal-full-title] Medical physics
  • [ISO-abbreviation] Med Phys
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA74043
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  •  go-up   go-down


30. Wessig C, Kenn W, Koltzenburg M, Bendszus M: Denervation hypertrophy may mimic local tumor spread on magnetic resonance imaging. Muscle Nerve; 2006 Jul;34(1):108-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a patient with an extensive paranasal sinus carcinoma.
  • Muscle denervation and pseudohypertrophy should be considered in the differential diagnosis of appropriate patients with suspected tumor recurrence.
  • [MeSH-major] Magnetic Resonance Imaging. Muscle Denervation. Neoplasm Recurrence, Local / diagnosis
  • [MeSH-minor] Adult. Carcinoma / surgery. Electromyography / methods. Functional Laterality / physiology. Humans. Hypertrophy. Male. Paranasal Sinus Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16583365.001).
  • [ISSN] 0148-639X
  • [Journal-full-title] Muscle & nerve
  • [ISO-abbreviation] Muscle Nerve
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Johnson ES, Zhou Y, Lillian Yau C, Prabhakar D, Ndetan H, Singh K, Preacely N: Mortality from malignant diseases-update of the Baltimore union poultry cohort. Cancer Causes Control; 2010 Feb;21(2):215-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this report, cancer mortality was updated to the year 2003 for 2,580 of the 2,639 subjects who worked exclusively in poultry plants.
  • Compared to the US general population, an excess of cancers of the buccal and nasal cavities and pharynx (base of the tongue, palate and other unspecified mouth, tonsil and oropharynx, nasal cavity/middle ear/accessory sinus), esophagus, recto-sigmoid/rectum/anus, liver and intrabiliary system, myelofibrosis, lymphoid leukemia and multiple myeloma was observed in particular subgroups or in the entire poultry cohort.
  • We hypothesize that oncogenic viruses present in poultry, and exposure to fumes, are candidates for an etiologic role to explain the excess occurrence of at least some of these cancers in the poultry workers.

  • MedlinePlus Health Information. consumer health - Cancer.
  • MedlinePlus Health Information. consumer health - Occupational Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19847658.001).
  • [ISSN] 1573-7225
  • [Journal-full-title] Cancer causes & control : CCC
  • [ISO-abbreviation] Cancer Causes Control
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / 1 R01 CA 30410-3; United States / NIOSH CDC HHS / OH / 1 R01 OH008071
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Netherlands
  •  go-up   go-down


32. [The efficiency of the radiobiological and clinical of the intraoperative radiation therapy in combination with distant gamma-radiation therapy of malignant tumors]. Radiats Biol Radioecol; 2005 Nov-Dec;45(6):664-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Average rates of total doses of IORT and EBRT were 67 +/- 2.1 Gy for patients with cancer of nasal cavity and of accessory nasal sinus, 50 +/- 1.8 Gy for patients with oral cavity cancer, 60 +/- 0.7 Gy for patients with lung cancer and 75 +/- 2.0 Gy for patients with sarcomas of soft tissues.
  • The combined treatment with IORT and EBRT resulted the significant reduction of recurrence rate among 5-year as compared with the combined treatment fot the control group: 37.5 +/- 5.3% and 65 +/- 5.1% of patients with cancer of nasal cavity and accessory nasal sinus; 55.8 +/- 6.3% and 80 +/- 5.9% of patients with oral cavity cancer; 57.8 +/- 6.7% and 75 +/- 5.8% of patients with non-small cell lung cancer and 32.7 +/- 6.1% and 72 +/- 6.7% of patients with sarcomas of soft tissues, respectively.

  • MedlinePlus Health Information. consumer health - Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16454332.001).
  • [ISSN] 0869-8031
  • [Journal-full-title] Radiatsionnaia biologiia, radioecologiia
  • [ISO-abbreviation] Radiats Biol Radioecol
  • [Language] RUS
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


33. Villano JL, Bressler L, Propp JM, Valyi-Nagy T, Martin IK, Dolecek TA, McCarthy BJ: Descriptive epidemiology of selected olfactory tumors. J Neurooncol; 2010 Oct;100(1):73-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this study was to more fully describe selected olfactory tumors using a large population-based cancer incidence database.
  • The Surveillance, Epidemiology and End Results (SEER) 9 registries limited-use data were reviewed from 1973 to 2006 for selected nasal cavity (C30.0) and accessory sinus (C31.0-31.9) tumors.
  • The majority of cases were squamous cell carcinoma (SCC), while the incidence of ON was greater than CND.
  • Survival rates were highest for ON (>70% alive at 5 years after diagnosis) and poorest for CND (44% alive at 5 years).

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • MedlinePlus Health Information. consumer health - Neuroblastoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 2000 Oct;110(10 Pt 1):1617-22 [11037813.001]
  • [Cites] Head Neck. 2009 Jun;31(6):748-58 [19189340.001]
  • [Cites] Lancet Oncol. 2001 Nov;2(11):683-90 [11902539.001]
  • [Cites] Cancer. 2002 Jul 15;95(2):243-8 [12124822.001]
  • [Cites] Laryngoscope. 2002 Aug;112(8 Pt 1):1450-5 [12172261.001]
  • [Cites] Cancer. 2002 May 15;94(10):2623-34 [12173330.001]
  • [Cites] Semin Cancer Biol. 2002 Dec;12(6):421-9 [12450728.001]
  • [Cites] Head Neck. 2004 May;26(5):435-41 [15122660.001]
  • [Cites] Cancer. 1982 Dec 1;50(11):2388-405 [7139532.001]
  • [Cites] Cancer Res. 1988 Jun 1;48(11):3282-7 [3365707.001]
  • [Cites] Cancer. 2004 Dec 1;101(11):2567-73 [15517582.001]
  • [Cites] Head Neck. 2005 Feb;27(2):138-49 [15654688.001]
  • [Cites] Adv Anat Pathol. 2005 May;12(3):134-43 [15900114.001]
  • [Cites] Am J Clin Pathol. 2005 Dec;124 Suppl:S110-21 [16468421.001]
  • [Cites] Otolaryngol Head Neck Surg. 2006 Sep;135(3):451-7 [16949981.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2007 Mar;133(3):276-80 [17372086.001]
  • [Cites] Cancer Treat Rev. 2007 Nov;33(7):631-45 [17329031.001]
  • [Cites] Otolaryngol Head Neck Surg. 2008 Apr;138(4):452-8 [18359353.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):343-50 [18374508.001]
  • [Cites] J Neurooncol. 2008 Nov;90(2):201-4 [18633576.001]
  • [Cites] Cancer. 2001 Dec 15;92(12):3012-29 [11753979.001]
  • (PMID = 20151173.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / HHSN261200800766P; United States / PHS HHS / / HHSN26100800766P
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS475576; NLM/ PMC4070851
  •  go-up   go-down


34. DeLaney TF: Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center. Technol Cancer Res Treat; 2007 Aug;6(4 Suppl):61-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Dose-escalation studies have been completed for early stage prostate cancer (in conjunction with Loma Linda University) and sarcomas of the cervical spine/base of skull and thoracolumbosacral spine.
  • Protocols are in progress or development for carcinoma of the nasopharynx, paranasal sinus carcinoma, non-small-cell lung carcinoma, locally advanced carcinoma of the prostate, hepatocellular carcinoma, and pancreatic cancer.

  • MedlinePlus Health Information. consumer health - Cancer.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17668954.001).
  • [ISSN] 1533-0346
  • [Journal-full-title] Technology in cancer research & treatment
  • [ISO-abbreviation] Technol. Cancer Res. Treat.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


35. Ruo Redda MG, Succo G, Guarneri A, Ragona R: Radiotherapy after surgery for advanced adenoid cystic carcinoma of paranasal sinus. Lancet Oncol; 2005 Dec;6(12):994-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiotherapy after surgery for advanced adenoid cystic carcinoma of paranasal sinus.
  • [MeSH-major] Carcinoma, Adenoid Cystic / radiotherapy. Carcinoma, Adenoid Cystic / surgery. Paranasal Sinus Neoplasms / radiotherapy. Paranasal Sinus Neoplasms / surgery

  • Genetic Alliance. consumer health - Adenoid Cystic Carcinoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16321768.001).
  • [ISSN] 1470-2045
  • [Journal-full-title] The Lancet. Oncology
  • [ISO-abbreviation] Lancet Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down






Advertisement